PATENT CLAIM ANALYSIS

Application Number: 15776913
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "165000"]

Abstract:
The present invention relates to a pharmaceutical composition containing a poorly soluble drug, hyaluronic acid, and a fatty acid, and to a method for preparing the same. The pharmaceutical composition of the present application has excellent stability even for long-term storage and allows a sustained release of the drug, thereby preventing an overdose of the drug and improving the therapeutic efficiency at an effected area.

Claim (Index 4):
The pharmaceutical composition of  claim 3 , wherein the fatty acid is one or more selected from the group consisting of myristoleic acid, palmitoleic acid, sapienic acid, oleic acid, elaidic acid, vaccenic acid, linoleic acid, linolenic acid, linoelaidic acid, arachidonic acid, eicosapentaenoic acid, erucic acid, docosahexaenoic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, and cerotic acid.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.61364
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13326477', '10511707', '10571005', '13825552', '12746754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7625989978803543
- 35 USC 102 Novelty (BERT): 0.502427669943201
- Combined Prediction Score: 0.736581865086639
- Mean Citation Score: 202.93644
- Max Citation Score: 209.82545
- Similarity Product: 138.85317105726298

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test